Significant J-shaped association between body mass index (BMI) and diabetic foot ulcers

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 4, 2011, Pages 402-409

  Sohn, Min Woong ^a,b   Budiman Mak, Elly ^a,c   Lee, Todd A ^a,d   Oh, Elissa ^b   Stuck, Rodney M ^a,c  

^a HINES VA HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Body mass index; Diabetic foot ulcers; Obesity; Peripheral arterial disease; Peripheral neuropathy

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETIC FOOT; DIABETIC PATIENT; DISEASE SEVERITY; DRUG ABUSE; FEMALE; FOLLOW UP; FOOT MALFORMATION; GENDER; HEMOGLOBIN BLOOD LEVEL; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPERTENSION; INCIDENCE; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MARRIAGE; ONYCHOMYCOSIS; PARALYSIS; PERIPHERAL NEUROPATHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; TIME; TINEA PEDIS; VISUAL IMPAIRMENT;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; DIABETIC FOOT; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; TIME FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 79955745290     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1193     Document Type: Article

References (50)

1. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293: 217-228.
2. Armstrong DG, Lavery LA, Wrobel JS, Vileikyte L. Quality of life in healing diabetic wounds: does the end justify the means? J Foot Ankle Surg 2008; 47: 278-282.
3. Mayfield JA, Reiber GE, Maynard C, Czerniecki JM, Caps MT, Sangeorzan BJ. Trends in lower limb amputation in the Veterans Health Administration, 1989-1998. J Rehabil Res Dev 2000; 37: 23-30.
4. Sohn MW, Lee TA, Stuck RM, Frykberg RG, Budiman-Mak E. Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care 2009; 32: 816-821.
5. Armstrong DG, Wrobel J, Robbins JM. Guest editorial: are diabetes-related wounds and amputations worse than cancer? Int Wound J 2007; 4: 286-287.
6. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Wagner EH. Patient-level estimates of the cost of complications in diabetes in a managed-care population. Pharmacoeconomics 1999; 16: 285-295.
7. Snyder RJ, Hanft JR. Diabetic foot ulcers-effects on quality of life, costs, and mortality and the role of standard wound care and advanced-care therapies in healing: a review. Ostomy Wound Manage 2009; 55: 28-38.
8. Huang ES, Basu A, O'Grady M, Capretta JC. Projecting the future diabetes population size and related costs for the U.S. Diabetes Care 2009; 32: 2225-2229.
9. Hartz AJ, Fischer ME, Bril G, et al. The association of obesity with joint pain and osteoarthritis in the HANES data. J Chronic Dis 1986; 39: 311-319.
10. Peltonen M, Lindroos AK, Torgerson JS. Musculoskeletal pain in the obese: a comparison with a general population and long-term changes after conventional and surgical obesity treatment. Pain 2003; 104: 549-557.
11. Tsuritani I, Honda R, Noborisaka Y, Ishida M, Ishizaki M, Yamada Y. Impact of obesity on musculoskeletal pain and difficulty of daily movements in Japanese middle-aged women. Maturitas 2002; 42: 23-30.
12. Merza Z, Tesfaye S. The risk factors for diabetic foot ulceration. The Foot 2003; 13: 125-129.
13. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999; 22: 1036-1042.
14. Crawford F, Inkster M, Kleijnen J, Fahey T. Predicting foot ulcers in patients with diabetes: a systematic review and meta-analysis. QJM 2007; 100: 65-86.
15. Boulton AJ, Kubrusly DB, Bowker JH, et al. Impaired vibratory perception and diabetic foot ulceration. Diabet Med 1986; 3: 335-337.
16. Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care 2006; 29: 1202-1207.
17. Kastenbauer T, Sauseng S, Sokol G, Auinger M, Irsigler K. A prospective study of predictors for foot ulceration in type 2 diabetes. J Am Podiatr Med Assoc 2001; 91: 343-350.
18. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998; 158: 157-162.
19. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Predictive value of foot pressure assessment as part of a population-based diabetes disease management program. Diabetes Care 2003; 26: 1069-1073.
20. McNeely MJ, Boyko EJ, Ahroni JH, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care 1995; 18: 216-219.
21. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 2000; 23: 606-611.
22. Sriussadaporn S, Mekanandha P, Vannasaeng S, et al. Factors associated with diabetic foot ulceration in Thailand: a case-control study. Diabet Med 1997; 14: 50-56.
23. Armstrong DG, Lavery LA, Holtz-Neiderer K, et al. Variability in activity may precede diabetic foot ulceration. Diabetes Care 2004; 27: 1980-1984.
24. Bennett PJ, Stocks AE, Whittam DJ. Analysis of risk factors for neuropathic foot ulceration in diabetes mellitus. J Am Podiatr Med Assoc 1996; 86: 112-116.
25. Litzelman DK, Marriott DJ, Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care 1997; 20: 1273-1278.
26. Peters EJ, Lavery LA. Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 2001; 24: 1442-1447.
27. Ledoux WR, Shofer JB, Smith DG, et al. Relationship between foot type, foot deformity, and ulcer occurrence in the high-risk diabetic foot. J Rehabil Res Dev 2005; 42: 665-672.
28. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004; 27(Suppl. 2): B10-B21.
29. Elia M. Obesity in the elderly. Obes Res 2001; 9(Suppl. 4): 244S-248S.
30. Hynes DM, Koelling K, Stroupe K, et al. Veterans' access to and use of Medicare and Veterans Affairs health care. Med Care 2007; 45: 214-223.
31. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27.
32. Etminan M. Pharmacoepidemiology II: the nested case-control study-a novel approach in pharmacoepidemiologic research. Pharmacotherapy 2004; 24: 1105-1109.
33. Essebag V, Platt RW, Abrahamowicz M, Pilote L. Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol 2005; 5: 5.
34. Essebag V, Genest J, Jr, Suissa S, Pilote L. The nested case-control study in cardiology. Am Heart J 2003; 146: 581-590.
35. Durazo-Arvizu R, McGee D, Li Z, Cooper R. Establishing the nadir of the body mass index-mortality relationship: a case study. J Am Stat Assoc 1997; 92: 1312-1319.
36. WHO Expert Committee on Physical Status. Physical Status: The Use and Interpretation of Anthropometry. WHO Technical Report Series 854. Geneva: World Health Organization: 1995.
37. Hills AP, Hennig EM, Byrne NM, Steele JR. The biomechanics of adiposity-structural and functional limitations of obesity and implications for movement. Obes Rev 2002; 3: 35-43.
38. Stuck RM, Sohn MW, Budiman-Mak E, Lee TA, Weiss KB. Charcot arthropathy risk elevation in the obese diabetic population. Am J Med 2008; 121: 1008-1014.
39. Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
40. Roth J, Qiang X, Marban SL, Redelt H, Lowell BC. The obesity pandemic: where have we been and where are we going? Obes Res 2004; 12(Suppl. 2): 88S-101S.
41. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, et al. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 2007; 10: 433-442.
42. Arena R, Lavie CJ. The obesity paradox and outcome in heart failure: is excess bodyweight truly protective? Future Cardiol 2010; 6: 1-6.
43. American Diabetes Association. American Diabetes Association Standards of medical care in diabetes-2010. Diabetes Care 2010; 33(Suppl. 1): S11-S61.
44. Frykberg RG, Zgonis T, Armstrong DG, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Footnkle Surg 2006; 45: S1-S66.
45. Veterans Health Administration, US Department of Veterans Affairs and US Department of Defense. VA/DOD Diabetes Clinical Practice Guideline for the Management of Diabetes Mellitus in Primary Care. 2003; Accessed 20 December, 2010.
46. National Institutes of Health Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998; 158: 1855-1867.
47. Collins EG, Langbein WE, Orebaugh C, et al. Cardiovascular training effect associated with polestriding exercise in patients with peripheral arterial disease. J Cardiovasc Nurs 2005; 20: 177-185.
48. Cadmus L, Patrick MB, Maciejewski ML, Topolski T, Belza B, Patrick DL. Community-based aquatic exercise and quality of life in persons with osteoarthritis. Med Sci Sports Exerc 2010; 42: 8-15.
49. Kinsinger LS, Jones KR, Kahwati L, et al. Design and dissemination of the MOVE! Weight-Management Program for Veterans. Prev Chronic Dis 2009; 6(3).
50. McNeely MJ, Boyko EJ. Type 2 diabetes prevalence in Asian Americans: results of a national health survey. Diabetes Care 2004; 27: 66-69.